STD Diagnostics Market Expansion Continues, with Forecast Valuation of $16.21 Billion by 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

STD Diagnostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for STD diagnostics has seen robust growth in the past few years. The market is projected to rise from $9.93 billion in 2024 to $10.86 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.4%. This growth during the historical period can be credited to factors such as epidemiological trends, the development of the healthcare infrastructure, advancements in pharmaceuticals, sexual education initiatives, and demographic changes.

STD Diagnostics Market Size Forecast: What's the Projected Valuation by 2029?
Expectations are high for the STD diagnostics market to experience robust expansion in the coming years, reaching a value of $16.21 billion in 2029 with a compound annual growth rate (CAGR) of 10.5%. Several factors are seen to contribute to this growth during the expected period like the rise of personalized medicine, enhancement of healthcare accessibility, strategic approach to population health, expansion of telemedicine, and the upward trend of STD cases. The period is also predicted to see significant developments such as the progress in point-of-care testing (POCT), advent of home testing kits, advancements in multiplex testing, targeted marketing initiatives, increased outreach, initiation of pre-exposure prophylaxis (prep) programs, along with a surge in incidence rates.

View the full report here:
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report

What Are the Drivers Transforming the STD Diagnostics Market?
The STD diagnostics market is rapidly expanding due to the increasing incidence of sexually transmitted diseases (STDs). STDs are infectious diseases that are spread through sexual interactions with someone who is already infected. STD diagnostics are essential for effective testing and detection of these diseases. According to data from the World Health Organization (WHO), a United Nations international agency devoted to enhancing global public health, over 1 million individuals worldwide acquire an STD daily in 2022. Moreover, a total of about 374 million new infections occur every year, of which chlamydia, gonorrhea, syphilis, and trichomoniasis account for one in 4 cases. Consequently, the increasing occurrences of STDs are driving the growth of the STD diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8507&type=smp

What Long-Term Trends Will Define the Future of the STD Diagnostics Market?
The development of STD diagnostic methods is a primary trend observed in the STD diagnostic market. Top industry participants are enhancing their testing centers and techniques to provide improved and quicker diagnosis of sexually transmitted infections. For instance, in May 2022, BD (Becton, Dickinson, and Company), a healthcare technology corporation based in the US, introduced a fully automated, high-capacity infectious disease molecular diagnostics platform called the BD CORTM MX/PX System. It simplifies and automates the molecular laboratory process, ensuring seamless progression from sample processing to diagnostic test outcomes. The BD CTGCTV2 molecular assay, capable of identifying the three most regularly occurring non-viral STIs: Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV), is the first test available on this new platform.

Which Segments in the STD Diagnostics Market Offer the Most Profit Potential?
The STD diagnostics market covered in this report is segmented -

1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, Other Types
2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare

Subsegments:
1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests
2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests
3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests
4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests
5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests
6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT)
7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests
8) By Other Types: Various Emerging Tests

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8507&type=smp

Which Firms Dominate the STD Diagnostics Market by Market Share and Revenue in 2025?
Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

Which Regions Offer the Highest Growth Potential in the STD Diagnostics Market?
North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the STD diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8507

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.